32 related articles for article (PubMed ID: 12885362)
21. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
22. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
23. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
24. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
Kong BH; Wang WX; Liu CS; Ma DX; Qu X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
[TBL] [Abstract][Full Text] [Related]
25. In situ use of suicide genes for cancer therapy.
Freeman SM; Whartenby KA; Freeman JL; Abboud CN; Marrogi AJ
Semin Oncol; 1996 Feb; 23(1):31-45. PubMed ID: 8607030
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J
J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071
[TBL] [Abstract][Full Text] [Related]
27. Molecular approaches to chemo-radiotherapy.
Marples B; Greco O; Joiner MC; Scott SD
Eur J Cancer; 2002 Jan; 38(2):231-9. PubMed ID: 11803140
[TBL] [Abstract][Full Text] [Related]
28. Association of the herpes simplex virus major tegument structural protein VP22 with chromatin.
Ingvarsdottir K; Blaho JA
Biochim Biophys Acta; 2010; 1799(3-4):200-6. PubMed ID: 19682615
[TBL] [Abstract][Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
